Research Progress of CLDN18.2 Protein in the Treatment of Malignant Tumors
In recent years, the overall incidence of global malignant tumors has shown a continuous upward trend. At present, the main clinical…
Tag: Introduction
Phospholipase A2 receptor (PLA2R) and THSD7A
Membranous nephropathy (MN) was first described in 1959. In 1959, Heymann et al. first established the classic MN rat model-Heymann…
Nano Secondary Antibodies
Antibodies are biological protein molecules that are produced by immune B cells after being stimulated by antigens that can specifically…
Early Markers of Apoptosis
The early stages of apoptosis signal transduction involve a complex cascade of signal molecules. Among them, early apoptosis signal transduction focuses…
What is Antibody KD
In chemistry, biochemistry, and pharmacology, the dissociation constant (KD) is a specific type of equilibrium constant used to measure the…
IHC Blocking
Immunohistochemistry is to apply the basic principle of immunology antigen-antibody reaction, that is, the principle of the specific binding of…
The Method of IHC Antigen Retrieval
Immunohistochemistry technology has become an indispensable and important method in the routine work and scientific research of the pathology laboratory. It…
Antibody Heavy and Light Chains
The structure of all immunoglobulins is basically the same, consisting of two heavy chains (Heavy, abbreviated as H) and two…
Oxidative Stress Markers
Oxidative stress is the oxidative modification of biological components in the body, such as proteins, nucleic acids and lipids. Since…
Competitive ELISA
In 1971, Engvall and Perlmann published an enzyme-linked immunosorbent assay (ELISA) for the quantitative determination of IgG, which made the…